Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of liposomal bupivacaine for interscalene block in arthroscopic shoulder surgery
ChiCTR2500102309Phase 4Not yet recruiting
- Sponsor
- Shenzhen Second People's Hospital
- Start
- May 2025
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine in postoperative pain (3 arms), sponsored by Shenzhen Second People's Hospital. Primary endpoint: Postoperative motor recovery time. Planned start May 2025; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500102309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102309.